Dr Deme Karikios is a Medical Oncologist and head of the department at Nepean Hospital in Sydney. He has a clinical and research interest in thoracic and gastrointestinal malignancies.

Deme also has a research interest in the costs and value of anticancer drugs, decisions about treatment with expensive unsubsidised anticancer drugs, and financial toxicity.

We spoke to him about the importance of quality of life outcomes, and looking beyond survival rates when discussing treatment success.